Milab

The multimodal Imaging Market is expected to display a steady growth of 5% due to the increasing incidences of chronic disorders | UnivDatos Market Insights

Retrieved on: 
Thursday, February 2, 2023
Carl Zeiss AG, PET/CT, Hospital, Canon Medical Systems Corporation, Disability, SPECT/CT, Midsayap Diagnostic Center and Hospital, Neurology, Oncology, Cardiology, PET/MRI, Research, PET-CT, Alzheimer's disease, Death, Milab, USD, WHO, DSM-IV codes, Disease, GE HealthCare, Growth, Multimodal, Human musculoskeletal system, Conditional sentence, Low back pain, Prevalence, COVID-19, Medical imaging, Cancer, Others, NOIDA

The multimodal imaging market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities.

Key Points: 
  • The multimodal imaging market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities.
  • This innovative report makes use of several analyses to get a closer outlook on the Multimodal Imaging market.
  • The multimodal imaging market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth.
  • Furthermore, this statistical market research repository examines and estimates the multimodal imaging market at the global and regional levels.

Global Pre-clinical Imaging Market Report to 2029 - Featuring Bruker, Siemens, General Electric and TriFoil Imaging Among Others - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 14, 2022
Research, Radiology, Utilities, Optical, Energy, Other Manufacturing, Health Technology, Science, Chemicals, Plastics, Biotechnology, Manufacturing, Health, PerkinElmer, CT, R, CT scan, MRI, Molecular imaging, Optical flow, Bruker, GE, Agilent Technologies, Research, Google Images, Investment, Government, Fujifilm, Scan (company), General Electric, PAT, Growth, Milab, Region, USD, 3D ultrasound, Medical imaging

The "Pre-clinical Imaging Market Analysis by Imaging Products (Optical Imaging, CT Imaging, Multi-Modal Imaging, MRI Imaging, Ultrasound Imaging, Reagents, Services), and by Region - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pre-clinical Imaging Market Analysis by Imaging Products (Optical Imaging, CT Imaging, Multi-Modal Imaging, MRI Imaging, Ultrasound Imaging, Reagents, Services), and by Region - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
  • Technological developments in the area of molecular imaging is a key driver for the growth of the global pre-clinical imaging market.
  • Nevertheless, stringent guidelines governing pre-clinical research and high cost of pre-clinical imaging treatment are expected to restrain the global market growth.
  • Based on imaging products, the market is segmented into optical imaging, CT imaging, multi-modal imaging, MRI imaging, PET/SPECT imaging devices, ultrasound imaging, photoacoustic (PAT) imaging, reagents, and services.

Small Animal Imaging (In-Vivo) Global Market Report 2022: Ukraine-Russia War Impact

Retrieved on: 
Thursday, November 24, 2022
Photon, Single-photon emission computed tomography, Animal, Research report, Disease, Development, Vega, Pathology, Tissue, COVID-19, CT scan, Optical flow, Transducer, Life Technologies, Economy, GDP, Organization, Rigaku, CT, LI-COR Biosciences, Biomarker, PerkinElmer, Growth, General Electric, Acquisition, OECD, Promega, Bruker, PET, Miltenyi Biotec, Area studies, Agilent Technologies, Maternity leave and the Organisation for Economic Co-operation and Development, Milab, HIV disease progression rates, Medical imaging, Healthcare, New England Biolabs, SPECT

The small animal imaging (in-vivo) market is expected to grow to $3.38 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%.

Key Points: 
  • The small animal imaging (in-vivo) market is expected to grow to $3.38 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%.
  • The small animal imaging (in-vivo) market consists of sales of small animal imaging (in-vivo) products by entities (organizations, sole traders, and partnerships) that are used to observe, define, and quantify normal and pathologic processes in living animal organs and tissues non-invasively.
  • Technological advancement is a key trend gaining popularity in the small animal imaging (in-vivo) market.Major companies operating in the small animal imaging (in vivo) market are focused on technological advancement to strengthen their position.
  • The small animal imaging(in-vivo)market research report is one of a series of new reports that provides small animal imaging(in-vivo)market statistics, including small animal imaging(in-vivo)industry global market size, regional shares, competitors with a small animal imaging(in-vivo)market share, detailed small animal imaging(in-vivo)market segments, market trends and opportunities, and any further data you may need to thrive in the small animal imaging(in-vivo)industry.

Biotech Company Noul Participates ASTMH, Giving Presentation at a Scientific Session

Retrieved on: 
Monday, October 31, 2022
Stockholm Environment Institute US Center, Hastings Banda, Tropical medicine, Artificial intelligence, Centers for Disease Control and Prevention, Diagnosis, View, National Institutes of Health, Multimedia, TED (conference), United States Agency for International Development, Biotechnology, History, Global health, Milab, Partnership, CEO, Patient, Society, State, Speech, Risk, Exhibition, Public sector, American Society of Tropical Medicine and Hygiene, Infection, Technology, International development, National, Innovation, Vaccine, Pharmaceutical industry, Malaria, Typhoon Noul (2015), Hygiene

Noul plans to introduce the innovativeness of malaria products and explore market opportunities in the public sector by participating in the ASTMH annual meeting.

Key Points: 
  • Noul plans to introduce the innovativeness of malaria products and explore market opportunities in the public sector by participating in the ASTMH annual meeting.
  • Also, Noul will give a speech at the Annual Innovations Pitch Competition on November 1.
  • Noul was selected within the final 5 teams for this competition, which is a TED Talk style speed presentation session presenting 'miLabTM, The Decentralized Malaria Diagnostic Platform'.
  • Meanwhile, Noul will set up a booth at this meeting and display miLabTMplatform and malaria cartridges.

Global Small Animal Imaging Market to Surpass US$ 1,692.5 Million by 2030 - Coherent Market Insights

Retrieved on: 
Wednesday, September 14, 2022
PerkinElmer, Siemens Healthineers, Adoption, Biomedicine, Cryosurgery, Incidence, Optical flow, Cancer, Ageing, Magnetic resonance, Prevalence, Center, Brain, World, World Health Organization, MRI, Acquisition, Growth, Magnetic resonance imaging, Diabetes, LI-COR Biosciences, Lung cancer, Government, Colon, Analysis, Breast cancer, Milab, Behavior, Cell, Degenerative disease, Battery Ventures, Fiat Global Small Engine, WHO, Foundation for the National Institutes of Health, History of the University of Maryland, College Park, Research, Prostate cancer, Animal, University, National Institute, Drug discovery, BRIC, NIH, Promega, Conditional sentence, Fujifilm, CAGR, Medical imaging, London Burkers

SEATTLE, Sept. 14, 2022 /PRNewswire/ -- According to Coherent Market Insights, the global small animal imaging market is estimated to be valued at US$ 977.7 million in 2022 and is expected to exhibit a CAGR of 7.1% over the forecast period (2022-2030).

Key Points: 
  • SEATTLE, Sept. 14, 2022 /PRNewswire/ -- According to Coherent Market Insights, the global small animal imaging market is estimated to be valued at US$ 977.7 million in 2022 and is expected to exhibit a CAGR of 7.1% over the forecast period (2022-2030).
  • These key trends are expected to aid in growth of the global small animal imaging market.
  • Furthermore, key players operating in the global small animal imaging market are focusing on adoption of inorganic growth strategies such as partnerships, acquisitions, collaborations, and others in order to expand their market presence in the global market.
  • Global Small Animal Imaging Market, By Product Type:

Global Small Animal Imaging Market to Surpass US$ 1,692.5 Million by 2030 - Coherent Market Insights

Retrieved on: 
Wednesday, September 14, 2022
PerkinElmer, Siemens Healthineers, Adoption, Biomedicine, Cryosurgery, Incidence, Optical flow, Cancer, Ageing, Magnetic resonance, Prevalence, Center, Brain, World, World Health Organization, MRI, Acquisition, Growth, Magnetic resonance imaging, Diabetes, LI-COR Biosciences, Lung cancer, Government, Colon, Analysis, Breast cancer, Milab, Behavior, Cell, Degenerative disease, Battery Ventures, Fiat Global Small Engine, WHO, Foundation for the National Institutes of Health, History of the University of Maryland, College Park, Research, Prostate cancer, Animal, University, National Institute, Drug discovery, BRIC, NIH, Promega, Conditional sentence, Fujifilm, CAGR, Medical imaging, London Burkers

SEATTLE, Sept. 14, 2022 /PRNewswire/ -- According to Coherent Market Insights, the global small animal imaging market is estimated to be valued at US$ 977.7 million in 2022 and is expected to exhibit a CAGR of 7.1% over the forecast period (2022-2030).

Key Points: 
  • SEATTLE, Sept. 14, 2022 /PRNewswire/ -- According to Coherent Market Insights, the global small animal imaging market is estimated to be valued at US$ 977.7 million in 2022 and is expected to exhibit a CAGR of 7.1% over the forecast period (2022-2030).
  • These key trends are expected to aid in growth of the global small animal imaging market.
  • Furthermore, key players operating in the global small animal imaging market are focusing on adoption of inorganic growth strategies such as partnerships, acquisitions, collaborations, and others in order to expand their market presence in the global market.
  • Global Small Animal Imaging Market, By Product Type:

Noul's Hydrogel Stamping is the potential core technology necessary for precise cancer diagnosis, study confirmed

Retrieved on: 
Wednesday, July 27, 2022
Diagnosis, Time, Research, CEO, HER2, Biomarker, Tissue, Solution, Mechanics, Massachusetts General Hospital, Health, Multimedia, Cell, KOSDAQ, Philosophy, Technology, ER, Patient, Blood, Precision medicine, Life, Breast cancer, Milab, Next Generation, Harvard Medical School, Interface, AI, IHC, Medical imaging, Medical device, Typhoon Noul (2015), Multiplexing

Hydrogel Stamping identified up to nine biomarkers that diagnose breast cancer even though the amount of antibody was reduced.

Key Points: 
  • Hydrogel Stamping identified up to nine biomarkers that diagnose breast cancer even though the amount of antibody was reduced.
  • This study confirmed the potential of Hydrogel based immunostaining as a core technology necessary for precise cancer diagnosis.
  • The study hasconcluded that the developed hydrogel stamping is a highly efficient and simple immunostaining method to stain cells and tissue samples.
  • In addition, when multiple fluorescence is applied to a hydrogel used for staining, multiple analysis is possible, enabling precise diagnosis.

Biotech Startup Noul Releases 2021 Sustainability Report

Retrieved on: 
Friday, July 8, 2022
KOSDAQ, Life, Sustainability reporting, Growth, Blood, Mechanics, DART, GRI, Philosophy, Milab, Technology, Health, Solution, AI, IPO, Multimedia, Renewable energy, Medical device, Public relations, Typhoon Noul (2015)

Disclose achievement and improvement on economic, social, and environmental commitments

Key Points: 
  • Disclose achievement and improvement on economic, social, and environmental commitments
    YONGIN, South Korea, July 8, 2022 /PRNewswire/ --Noul Co., Ltd., (376930.KR), a KOSDAQ-listed biotech startup, has released its 2021 Sustainability Report, including corporate sustainability performances.
  • Noul is a biotech startup that develops and manufactures next-generation diagnostic platforms.
  • The 2021 Noul Sustainability Report was prepared in accordance with the GRI standards.
  • The report consisted of 1) introduction of the company and product, 2) sustainability implementation system and governance for sustainability, and 3) key achievements.

Biotech Startup Noul Releases 2021 Sustainability Report

Retrieved on: 
Friday, July 8, 2022
Sustainability reporting, GRI, Growth, KOSDAQ, Blood, AI, Milab, DART, Renewable energy, Medical device, Typhoon Noul (2015)

Disclose achievement and improvement on economic, social, and environmental commitments

Key Points: 
  • Disclose achievement and improvement on economic, social, and environmental commitments
    YONGIN, South Korea, July 8, 2022 /PRNewswire/ --Noul Co., Ltd., (376930.KR), a KOSDAQ-listed biotech startup, has released its 2021 Sustainability Report, including corporate sustainability performances.
  • Noul is a biotech startup that develops and manufactures next-generation diagnostic platforms.
  • The 2021 Noul Sustainability Report was prepared in accordance with the GRI standards.
  • The report consisted of 1) introduction of the company and product, 2) sustainability implementation system and governance for sustainability, and 3) key achievements.